Header Logo

Connection

Kabirullah Lutfy to Animals

Back to Details
This is a "connection" page, showing publications Kabirullah Lutfy has written about Animals.
Kabirullah Lutfy
Connection Strength
3.727
Animals
  1. Chronic Exposure to E-Cigarettes Elevates CYP2A5 Activity, Protein Expression, and Cotinine-Induced Production of Reactive Oxygen Species in Mice. Drug Metab Dispos. 2024 Feb 14; 52(3):171-179.
    View in: PubMed
    Score: 0.167
  2. Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL/6 mice. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Apr 20; 131:110941.
    View in: PubMed
    Score: 0.166
  3. Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo. Drug Metab Dispos. 2022 Dec; 50(12):1454-1463.
    View in: PubMed
    Score: 0.152
  4. The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal. J Neurosci Res. 2020 08; 98(8):1549-1560.
    View in: PubMed
    Score: 0.129
  5. The role of pituitary adenylyl cyclase-activating polypeptide in the motivational effects of addictive drugs. Neuropharmacology. 2020 07; 171:108109.
    View in: PubMed
    Score: 0.128
  6. Emerging evidence for the role of pituitary adenylate cyclase-activating peptide in neuropsychiatric disorders. Prog Mol Biol Transl Sci. 2019; 167:143-157.
    View in: PubMed
    Score: 0.121
  7. The role of endogenous pituitary adenylyl cyclase activating polypeptide (PACAP) in nicotine self-administration, reward and aversion. Pharmacol Biochem Behav. 2019 06; 181:46-52.
    View in: PubMed
    Score: 0.119
  8. A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice. Alcohol Clin Exp Res. 2018 Feb; 42(2):461-471.
    View in: PubMed
    Score: 0.109
  9. Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol. 2017 Oct; 235(1):R13-R31.
    View in: PubMed
    Score: 0.107
  10. Nicotine pretreatment reduced cocaine-induced CPP and its reinstatement in a sex- and dose-related manner in adult C57BL/6J mice. Pharmacol Biochem Behav. 2017 08; 159:84-89.
    View in: PubMed
    Score: 0.106
  11. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Neuroscience. 2016 08 04; 329:318-25.
    View in: PubMed
    Score: 0.097
  12. The role of endogenous beta-endorphin and enkephalins in ethanol reward. Neuropharmacology. 2013 Oct; 73:290-300.
    View in: PubMed
    Score: 0.080
  13. The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice. Eur J Pharmacol. 2013 May 05; 707(1-3):41-5.
    View in: PubMed
    Score: 0.078
  14. The rewarding action of acute cocaine is reduced in ß-endorphin deficient but not in µ opioid receptor knockout mice. Eur J Pharmacol. 2012 Jul 05; 686(1-3):50-4.
    View in: PubMed
    Score: 0.074
  15. The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide. Eur J Pharmacol. 2012 May 05; 682(1-3):86-91.
    View in: PubMed
    Score: 0.073
  16. Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors. J Neurochem. 2012 Mar; 120(6):1108-16.
    View in: PubMed
    Score: 0.072
  17. The role of endogenous dynorphin in ethanol-induced state-dependent CPP. Behav Brain Res. 2012 Feb 01; 227(1):58-63.
    View in: PubMed
    Score: 0.071
  18. Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration. Eur J Pharmacol. 2011 Jan 15; 650(2-3):563-7.
    View in: PubMed
    Score: 0.066
  19. Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice. Biol Psychiatry. 2010 Aug 01; 68(3):223-30.
    View in: PubMed
    Score: 0.064
  20. The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice. Psychopharmacology (Berl). 2009 Jun; 204(3):457-63.
    View in: PubMed
    Score: 0.059
  21. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine. Neuroscience. 2008 Aug 26; 155(3):597-602.
    View in: PubMed
    Score: 0.056
  22. Alterations in the level of OFQ/N-IR in rat brain regions by cocaine. Neuropharmacology. 2008 Aug; 55(2):198-203.
    View in: PubMed
    Score: 0.056
  23. The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice. Psychopharmacology (Berl). 2008 Apr; 197(3):443-8.
    View in: PubMed
    Score: 0.055
  24. The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine. Neuropharmacology. 2008 Mar; 54(3):564-8.
    View in: PubMed
    Score: 0.054
  25. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference. Neuropharmacology. 2007 May; 52(6):1336-41.
    View in: PubMed
    Score: 0.051
  26. Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J Neurochem. 2006 Dec; 99(5):1321-7.
    View in: PubMed
    Score: 0.050
  27. Differential involvement of enkephalins in analgesic tolerance, locomotor sensitization, and conditioned place preference induced by morphine. Behav Neurosci. 2006 Feb; 120(1):10-5.
    View in: PubMed
    Score: 0.048
  28. E-Cigarette Smoke Exposure Elevates Renal MR Expression and Induces BP Elevation. Hypertension. 2025 Sep; 82(9):1492-1504.
    View in: PubMed
    Score: 0.046
  29. Orphanin FQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats. J Psychiatry Neurosci. 2004 Mar; 29(2):116-23.
    View in: PubMed
    Score: 0.042
  30. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12; 23(32):10331-7.
    View in: PubMed
    Score: 0.041
  31. Brain-derived neurotrophic factor overexpression in taste buds diminishes chemotherapy induced taste loss. Eur J Neurosci. 2022 10; 56(7):4967-4982.
    View in: PubMed
    Score: 0.038
  32. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl). 2002 Nov; 164(2):168-76.
    View in: PubMed
    Score: 0.038
  33. Sensitization does not develop to cocaine-induced potentiation of the antinociceptive effect of morphine. Brain Res Bull. 2002 May; 58(1):7-12.
    View in: PubMed
    Score: 0.037
  34. Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol. 2001 Oct; 134(3):529-34.
    View in: PubMed
    Score: 0.035
  35. Decreased 11ß-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice. Hypertension. 2021 06; 77(6):1940-1952.
    View in: PubMed
    Score: 0.034
  36. Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl). 2001 Feb; 154(1):1-7.
    View in: PubMed
    Score: 0.034
  37. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol. 2000 Dec; 131(8):1684-8.
    View in: PubMed
    Score: 0.033
  38. Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice. Clin Sci (Lond). 2019 11 15; 133(21):2189-2202.
    View in: PubMed
    Score: 0.031
  39. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance. Eur J Pharmacol. 1999 Nov 12; 384(1):1-5.
    View in: PubMed
    Score: 0.031
  40. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol Res. 1999 Nov; 40(5):435-42.
    View in: PubMed
    Score: 0.031
  41. A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers. J Neurosci Methods. 2019 10 01; 326:108376.
    View in: PubMed
    Score: 0.030
  42. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport. 1999 Jan 18; 10(1):103-6.
    View in: PubMed
    Score: 0.029
  43. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice. Pharmacol Res. 1998 Dec; 38(6):453-60.
    View in: PubMed
    Score: 0.029
  44. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice. Pharmacol Res. 1998 Apr; 37(4):295-302.
    View in: PubMed
    Score: 0.028
  45. Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity. Int J Obes (Lond). 2018 12; 42(12):1999-2011.
    View in: PubMed
    Score: 0.028
  46. a7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling. Endocrinology. 2018 02 01; 159(2):931-944.
    View in: PubMed
    Score: 0.027
  47. Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes. Glia. 2017 12; 65(12):2003-2023.
    View in: PubMed
    Score: 0.027
  48. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain. 1997 Mar; 70(1):31-40.
    View in: PubMed
    Score: 0.026
  49. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice. Brain Res. 1996 Dec 16; 743(1-2):17-23.
    View in: PubMed
    Score: 0.025
  50. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 1996 Aug 26; 731(1-2):171-81.
    View in: PubMed
    Score: 0.025
  51. Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test. Pharmacol Biochem Behav. 1996 Jun; 54(2):495-500.
    View in: PubMed
    Score: 0.024
  52. Increased glycogen synthase kinase-3ß and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity. Int J Obes (Lond). 2016 08; 40(8):1233-41.
    View in: PubMed
    Score: 0.024
  53. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol. 1995 Jan 24; 273(1-2):187-9.
    View in: PubMed
    Score: 0.022
  54. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice. NIDA Res Monogr. 1995; 147:220-33.
    View in: PubMed
    Score: 0.022
  55. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015 Mar 12; 519(7542):242-6.
    View in: PubMed
    Score: 0.022
  56. Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia. Eur J Pharmacol. 1994 Nov 24; 265(3):171-4.
    View in: PubMed
    Score: 0.022
  57. 11ß-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue. Am J Physiol Endocrinol Metab. 2015 Jan 01; 308(1):E84-95.
    View in: PubMed
    Score: 0.022
  58. Anti-nociception mediated by a ? opioid receptor agonist is blocked by a d receptor agonist. Br J Pharmacol. 2015 Jan; 172(2):691-703.
    View in: PubMed
    Score: 0.022
  59. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011. Eur J Pharmacol. 1994 Feb 11; 252(3):261-6.
    View in: PubMed
    Score: 0.021
  60. Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice. Am J Physiol Endocrinol Metab. 2014 Mar 01; 306(5):E543-51.
    View in: PubMed
    Score: 0.021
  61. Alterations in phosphorylated CREB expression in different brain regions following short- and long-term morphine exposure: relationship to food intake. J Obes. 2013; 2013:764742.
    View in: PubMed
    Score: 0.020
  62. Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2. Peptides. 2013 Sep; 47:99-109.
    View in: PubMed
    Score: 0.020
  63. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 1993 Jul 09; 616(1-2):83-8.
    View in: PubMed
    Score: 0.020
  64. Specific reduction of G6PT may contribute to downregulation of hepatic 11ß-HSD1 in diabetic mice. J Mol Endocrinol. 2013 Apr; 50(2):167-78.
    View in: PubMed
    Score: 0.019
  65. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012 Jul; 23(7):334-42.
    View in: PubMed
    Score: 0.018
  66. Effect of nicotine on body composition in mice. J Endocrinol. 2012 Mar; 212(3):317-26.
    View in: PubMed
    Score: 0.018
  67. Modification of morphine-induced analgesia and toxicity by pertussis toxin. Brain Res. 1991 Mar 29; 544(2):191-5.
    View in: PubMed
    Score: 0.017
  68. The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther. 1991 Feb; 256(2):575-80.
    View in: PubMed
    Score: 0.017
  69. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia. 2011 Feb; 54(2):440-50.
    View in: PubMed
    Score: 0.017
  70. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation. Brain Res. 1990 Oct 08; 529(1-2):143-8.
    View in: PubMed
    Score: 0.017
  71. The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons. Neuropharmacology. 2010 Sep; 59(3):190-200.
    View in: PubMed
    Score: 0.016
  72. Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake. Neuroscience. 2010 May 05; 167(2):554-66.
    View in: PubMed
    Score: 0.016
  73. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2010 Feb; 31(1):98-132.
    View in: PubMed
    Score: 0.016
  74. Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur J Pharmacol. 1989 Nov 07; 170(3):193-200.
    View in: PubMed
    Score: 0.015
  75. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction. Neuroscience. 2008 Oct 15; 156(3):788-99.
    View in: PubMed
    Score: 0.014
  76. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J Mol Endocrinol. 2008 Aug; 41(2):53-64.
    View in: PubMed
    Score: 0.014
  77. Cellular colocalization and coregulation between hypothalamic pro-TRH and prohormone convertases in hypothyroidism. Am J Physiol Endocrinol Metab. 2007 Jan; 292(1):E175-86.
    View in: PubMed
    Score: 0.012
  78. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology. 2006 Nov; 147(11):5061-8.
    View in: PubMed
    Score: 0.012
  79. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes. 2005 Jan; 54(1):32-40.
    View in: PubMed
    Score: 0.011
  80. Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin. Behav Brain Res. 2002 Apr 01; 131(1-2):97-103.
    View in: PubMed
    Score: 0.009
  81. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol Biochem Behav. 1992 Aug; 42(4):685-92.
    View in: PubMed
    Score: 0.005
  82. Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci. 1992; 50(8):591-7.
    View in: PubMed
    Score: 0.004
  83. Dissociation of opioid receptor upregulation and functional supersensitivity. Pharmacol Biochem Behav. 1991 Apr; 38(4):853-9.
    View in: PubMed
    Score: 0.004
  84. Species differences in mu- and delta-opioid receptors. Eur J Pharmacol. 1991 Jan 25; 193(1):105-8.
    View in: PubMed
    Score: 0.004
  85. Tolerance develops to spinal morphine analgesia but not morphine-induced convulsions. Eur J Pharmacol. 1990 Jan 25; 176(1):63-7.
    View in: PubMed
    Score: 0.004
  86. In vitro d-amphetamine and cocaine increase opioid binding in mouse brain homogenate. NIDA Res Monogr. 1990; 105:522-3.
    View in: PubMed
    Score: 0.004
  87. Differentiation of spinal and supraspinal opioid receptors by morphine tolerance. Life Sci. 1990; 46(5):343-50.
    View in: PubMed
    Score: 0.004
  88. Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia. Brain Res. 1989 Apr 17; 485(1):176-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.